SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-251597
Filing Date
2021-08-19
Accepted
2021-08-19 16:49:02
Documents
12
Period of Report
2021-03-24
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K/A d214545d8ka.htm   iXBRL 8-K/A 23933
  Complete submission text file 0001193125-21-251597.txt   155960

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA krys-20210324.xsd EX-101.SCH 2898
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20210324_lab.xml EX-101.LAB 19601
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20210324_pre.xml EX-101.PRE 12304
5 EXTRACTED XBRL INSTANCE DOCUMENT d214545d8ka_htm.xml XML 4616
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38210 | Film No.: 211190798
SIC: 2836 Biological Products, (No Diagnostic Substances)